# CUTE (Chronic Urticaria Treatment Evaluation)

> **NCT00264303** · PHASE4 · COMPLETED · sponsor: **UCB Pharma** · enrollment: 886 (actual)

## Conditions studied

- Chronic Idiopathic Urticaria

## Interventions

- **DRUG:** Levocetirizine
- **DRUG:** Desloratadine

## Key facts

- **NCT ID:** NCT00264303
- **Lead sponsor:** UCB Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-12
- **Primary completion:** 2007-01
- **Final completion:** 2007-01
- **Target enrollment:** 886 (ACTUAL)
- **Last updated:** 2011-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00264303

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00264303, "CUTE (Chronic Urticaria Treatment Evaluation)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00264303. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*